Tobramycin Inhalation Powder: A Review of Its Use in the Treatment of Chronic Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis-Reference-Cited by-同舟云学术

Tobramycin Inhalation Powder: A Review of Its Use in the Treatment of Chronic Pseudomonas aeruginosa Infection in Patients with Cystic Fibrosis

Published:2013-11 Issue:16 Volume:73 Page:1815-1827
ISSN:0012-6667
Container-title:Drugs
language:en
Short-container-title:Drugs

Author:

McKeage Kate

Publisher

Springer Science and Business Media LLC

Subject

Pharmacology (medical)

Link

http://link.springer.com/content/pdf/10.1007/s40265-013-0141-0.pdf

Reference47 articles.

1. Parkins MD, Elborn JS. Tobramycin Inhalation PowderTM: a novel drug delivery system for treating chronic Pseudomonas aeruginosa infection in cystic fibrosis. Expert Rev Respir Med. 2011;5(5):609–22.

2. VanDevanter DR, Geller DE. Tobramycin administered by the TOBI Podhaler for persons with cystic fibrosis: a review. Med Devices (Auckl). 2011. doi: 10.2147/MDER.S16360 .

3. Farrell PM. The prevalence of cystic fibrosis in the European Union. J Cyst Fibros. 2008;7:450–3.

4. Høiby N. Recent advances in the treatment of Pseudomonas aeruginosa infections in cystic fibrosis. BMC Med. 2011;9:32.

5. Flume PA, O’Sullivan BP, Robinson KA, et al. Cystic fibrosis pulmonary guidelines: chronic medications for maintenance of lung health. Am J Respir Crit Care Med. 2007;176(10):957–69.

Cited by 25 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Inhalable tobramycin EEG powder formulation for treating Pseudomonas aeruginosa-induced lung infection;International Journal of Pharmaceutics;2024-09

2. Surface modification strategies for high-dose dry powder inhalers;Journal of Pharmaceutical Investigation;2021-04-22

3. The effect of particle size of inhaled tobramycin dry powder on the eradication of Pseudomonas aeruginosa biofilms;European Journal of Pharmaceutical Sciences;2021-03

4. Development of inhaled formulation of modified clofazimine as an alternative to treatment of tuberculosis;Journal of Drug Delivery Science and Technology;2020-08

5. Drugs for Gram-Negative Bugs From 2010–2019: A Decade in Review;Open Forum Infectious Diseases;2020-07-01